SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hiroyo Kuwabara, Kirsten Westerhout, Maarten Treur, Karin Cerri, Joerg Mahlich, Hiroshi Yatsuhashi, Cost-effectiveness analysis of simeprevir in combination with peginterferon and ribavirin for treatment-naïve chronic hepatitis C genotype 1 patients in Japan, Journal of Medical Economics, 2015, 18, 7, 502

    CrossRef

  2. 2
    Pierre Nahon, Angela Sutton, Marianne Ziol, Jessica Zucman-Rossi, Jean-Claude Trinchet, Nathalie Ganne-Carrié, Genetic risk markers for hepatocellular carcinoma in patients with alcoholic liver disease, Hepatic Oncology, 2015, 2, 1, 63

    CrossRef

  3. 3
    Sang Soo Lee, Sook-Hyang Jeong, Eun Sun Jang, Young Seok Kim, Youn Jae Lee, Eun Uk Jung, In Hee Kim, Si Hyun Bae, Han Chu Lee, Mee-Kyung Kee, Chun Kang, Prospective cohort study on the outcomes of hepatitis C virus-related cirrhosis in South Korea, Journal of Gastroenterology and Hepatology, 2015, 30, 8
  4. 4
    Yo-ichi Yamashita, Daisuke Imai, Yuki Bekki, Koichi Kimura, Yoshiriro Matsumoto, Hidekazu Nakagawara, Toru Ikegami, Tomoharu Yoshizumi, Ken Shirabe, Shinichi Aishima, Yoshihiko Maehara, Surgical Outcomes of Hepatic Resection for Hepatitis B Virus Surface Antigen-Negative and Hepatitis C Virus Antibody-Negative Hepatocellular Carcinoma, Annals of Surgical Oncology, 2015, 22, 7, 2279

    CrossRef

  5. 5
    Shintaro Mikami, Ryosuke Tateishi, Shu Hagiwara, Masaya Sato, Tatsuya Minami, Koji Uchino, Kenichiro Enooku, Takahisa Sato, Hayato Nakagawa, Ryota Masuzaki, Yoshinari Asaoka, Yuji Kondo, Shuichiro Shiina, Hitoshi Ikeda, Masao Omata, Haruhiko Yoshida, Kazuhiko Koike, Tumor markers are more useful in patients undergoing surveillance for hepatocellular carcinoma with unreliable results by ultrasonography, Hepatology Research, 2015, 45, 4
  6. 6
    Kasper J. Andersen, Henning Grønbæk, Gerda Elisabeth Villadsen, Anders Riegels Knudsen, Peter Ott, Hendrik Vildstrup, Dennis Tønner Nielsen, Arindam Bharadwaz, Chemoembolization of intermediate stage hepatocellular carcinomas: Results from a Nordic tertiary liver cancer center, Indian Journal of Gastroenterology, 2014, 33, 4, 322

    CrossRef

  7. 7
    Shinji Katsushima, Takefumi Nakamura, Yoshio Sumida, Saiyu Tanaka, Tatsuro Kobata, Motoshige Nabeshima, Akihiro Okano, Takehiro Sando, Toshihiko Kawasaki, Kazuyo Fujimura, Yasuyuki Nagao, Masahiro Arai, Kazuhiro Tsuji, Comparison between phlebotomy and IFN-based therapy in hepatitis C patients aged 70 years or older: hepatocarcinogenesis and overall survival, multicenter study, Kanzo, 2014, 55, 6, 335

    CrossRef

  8. 8
    Yan-Di Xie, Bo Feng, Yan Gao, Lai Wei, Effect of abstinence from alcohol on survival of patients with alcoholic cirrhosis: A systematic review and meta-analysis, Hepatology Research, 2014, 44, 4
  9. 9
    Li-Hung Tsai, Chang-Ming Lin, Shu-Chen Chiang, Chia-Ling Chen, Su-Jane Lan, Lai-Chu See, Symptoms and Distress Among Patients With Liver Cirrhosis but Without Hepatocellular Carcinoma in Taiwan, Gastroenterology Nursing, 2014, 37, 1, 49

    CrossRef

  10. 10
    Suwen Qi, Zhiguang Tu, Xin Ouyang, Linxian Wang, Wujian Peng, Anji Cai, Yong Dai, Comparison of the metabolic profiling of hepatitis B virus-infected cirrhosis and alcoholic cirrhosis patients by using 1H NMR-based metabonomics, Hepatology Research, 2012, 42, 7
  11. 11
    J. Wiegand, M. Kühne, P. Pradat, J. Mössner, C. Trepo, H. L. Tillmann, Different patterns of decompensation in patients with alcoholic vs. non-alcoholic liver cirrhosis, Alimentary Pharmacology & Therapeutics, 2012, 35, 12
  12. 12
    C-T Chou, R-C Chen, C-W Lee, C-J Ko, H-K Wu, Y-L Chen, Prediction of microvascular invasion of hepatocellular carcinoma by pre-operative CT imaging, The British Journal of Radiology, 2012, 85, 1014, 778

    CrossRef

  13. 13
    Sudul Senanayake, Madunil Niriella, Sanjaya Weerasinghe, Anuradhani Kasturiratne, Jerome de Alwis, Arjuna de Silva, Anuradha Dassanayake, Hithanadura de Silva, Survival of patients with alcoholic and cryptogenic cirrhosis without liver transplantation: a single center retrospective study, BMC Research Notes, 2012, 5, 1, 663

    CrossRef

  14. You have free access to this content14
    Adrian M. Di Bisceglie, Anne M. Stoddard, Jules L. Dienstag, Mitchell L. Shiffman, Leonard B. Seeff, Herbert L. Bonkovsky, Chihiro Morishima, Elizabeth C. Wright, Kristin K. Snow, William M. Lee, Robert J. Fontana, Timothy R. Morgan, Marc G. Ghany, Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon , Hepatology, 2011, 53, 4
  15. 15
    Weijing Sun, Davendra Sohal, Daniel G. Haller, Kristine Mykulowycz, Mark Rosen, Michael C. Soulen, Millie Caparro, Ursina R. Teitelbaum, Bruce Giantonio, Peter J. O'Dwyer, Abraham Shaked, Rajender Reddy, Kim Olthoff, Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinoma, Cancer, 2011, 117, 14
  16. 16
    W. Alazawi, M. Cunningham, J. Dearden, G. R. Foster, Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection, Alimentary Pharmacology & Therapeutics, 2010, 32, 3